Adicet Bio Total Assets

Adicet Bio (0HX7.L) currently reports a total assets of $150M as of June 2026. That compares with $160M in the prior-year period — down 9.1% year over year. Use the charts on this page to explore Adicet Bio's total assets history and peer comparisons.

Adicet Bio's total assets decreased from $160M to $150M — a 9.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Adicet Bio reported $150M in total assets as of June 2026. That compares with $160M in the prior-year period — down 9.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adicet Bio, and consider following 0HX7.L for alerts when major investors trade the stock.

Adicet Bio is classified in the Healthcare sector. On total assets, it currently shows $150M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 0HX7.L with unrelated industries.